Onyx Healthcare (6569) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 醫揚

Onyx Healthcare (6569) reported revenue of NT$82.9 million for Oct 2026, -9.5% year on year and -31.9% from the previous month. Revenue for Jan–Oct 2026 was NT$1.2 billion (+10.3% year on year).

In Oct 2026, it ranked No. 85 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$109.9 million24/10Nov 2024 NT$103.9 millionDec 2024 NT$168.8 millionJan 2025 NT$82.2 millionFeb 2025 NT$97.5 million25/02Mar 2025 NT$130.2 millionApr 2025 NT$105.3 millionMay 2025 NT$114.4 millionJun 2025 NT$137.7 million25/06Jul 2025 NT$111.2 millionAug 2025 NT$94.5 millionSep 2025 NT$124.5 millionOct 2025 NT$91.6 million25/10Nov 2025 NT$95.9 millionDec 2025 NT$128.2 millionJan 2026 NT$78 millionFeb 2026 NT$105.1 million26/02Mar 2026 NT$194.3 millionApr 2026 NT$96.6 millionMay 2026 NT$171.4 millionJun 2026 NT$161.2 million26/06Jul 2026 NT$55 millionAug 2026 NT$135.3 millionSep 2026 NT$121.8 millionOct 2026 NT$82.9 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$82.9 million-9.5%-31.9%
Sep 2026NT$121.8 million-2.1%-9.9%
Aug 2026NT$135.3 million+43.2%+146.1%
Jul 2026NT$55 million-50.6%-65.9%
Jun 2026NT$161.2 million+17.0%-5.9%
May 2026NT$171.4 million+49.8%+77.4%
Apr 2026NT$96.6 million-8.3%-50.3%
Mar 2026NT$194.3 million+49.2%+84.9%
Feb 2026NT$105.1 million+7.7%+34.6%
Jan 2026NT$78 million-5.0%-39.1%
Dec 2025NT$128.2 million-24.1%+33.6%
Nov 2025NT$95.9 million-7.6%+4.7%
Oct 2025NT$91.6 million-16.6%-26.4%
Sep 2025NT$124.5 million+34.6%+31.8%
Aug 2025NT$94.5 million-6.4%-15.0%
Jul 2025NT$111.2 million+22.7%-19.3%
Jun 2025NT$137.7 million+19.5%+20.4%
May 2025NT$114.4 million+60.1%+8.6%
Apr 2025NT$105.3 million-6.5%-19.1%
Mar 2025NT$130.2 million+15.4%+33.5%
Feb 2025NT$97.5 million+11.0%+18.7%
Jan 2025NT$82.2 million+10.1%-51.3%
Dec 2024NT$168.8 million+8.5%+62.5%
Nov 2024NT$103.9 million+4.0%-5.5%
Oct 2024NT$109.9 million-38.7%+18.8%

Jan–Oct 2026 cumulative: NT$1.2 billion (+10.3% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Onyx Healthcare vs PEC / Onyx Healthcare vs Lotus Pharm / Onyx Healthcare vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16